Outcomes of Radium-223 Therapy in Women With HR+ Bone-Metastatic Breast Cancer Receiving Endocrine Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials
Breast Cancer Res Treat 2023 Dec 20;[EPub Ahead of Print], HS Rugo, CH Van Poznak, P Neven, I Danielewicz, SC Lee, M Campone, JYK Chik, E Vega Alonso, B Naume, E Brain, JM Siegel, R Li, D Uema, VJ Wagner, RE ColemanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.